{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:33:08Z","timestamp":1781332388411,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,14]]},"DOI":"10.7759\/cureus.21246","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T17:26:57Z","timestamp":1642181217000},"source":"Crossref","is-referenced-by-count":5,"title":["Post-COVID-19 Guillain-Barr\u00e9 Syndrome: A Case Report With Literature Review"],"prefix":"10.7759","author":[{"given":"Nidhi","family":"Kaeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Kabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadya","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takshak","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salva","family":"Ameena M S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.nrl.0000117821.35196.0b","article-title":"Variants and mimics of Guillain Barr\u00e9 syndrome","volume":"10","author":"Levin KH","year":"2004","unstructured":"Levin KH. Variants and mimics of Guillain Barr\u00e9 syndrome. Neurologist. 2004, 10:61-74. 10.1097\/01.nrl.0000117821.35196.0b","journal-title":"Neurologist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000055091.96905.d0","article-title":"Guillain-Barr\u00e9 syndrome: a prospective, population-based incidence and outcome survey","volume":"60","author":"Chi\u00f2 A","year":"2003","unstructured":"Chi\u00f2 A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R. Guillain-Barr\u00e9 syndrome: a prospective, population-based incidence and outcome survey. Neurology. 2003, 60:1146-50. 10.1212\/01.wnl.0000055091.96905.d0","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs BC","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study. Neurology. 1998, 51:1110-5. 10.1212\/wnl.51.4.1110","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10108-x","article-title":"Immune-mediated neurological syndromes in SARS-CoV-2-infected patients","volume":"268","author":"Guilmot A","year":"2021","unstructured":"Guilmot A, Maldonado Slootjes S, Sellimi A, et al.. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2021, 268:751-7. 10.1007\/s00415-020-10108-x","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo Y","year":"2020","unstructured":"Zuo Y, Yalavarthi S, Shi H, et al.. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020, 5:e138999. 10.1172\/jci.insight.138999","journal-title":"JCI Insight"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore JB","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020, 368:473-4. 10.1126\/science.abb8925","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"44","author":"Hadden RD","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Ann Neurol. 1998, 44:780-8. 10.1002\/ana.410440512","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370704","article-title":"Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies","volume":"37 Suppl 1","author":"van der Mech\u00e9 FG","year":"1995","unstructured":"van der Mech\u00e9 FG, van Doorn PA. Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol. 1995, 37 Suppl 1:S14-31. 10.1002\/ana.410370704","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4067\/s0034-98872021000400527","article-title":"[Neurology and COVID-19: case series of neurological complications in 96 patients admitted at a university hospital]","volume":"149","author":"Godoy-Sant\u00edn J","year":"2021","unstructured":"Godoy-Sant\u00edn J, Bravo-Grau S, Nu\u00f1ez F, et al.. [Neurology and COVID-19: case series of neurological complications in 96 patients admitted at a university hospital]. Rev Med Chil. 2021, 149:527-32. 10.4067\/s0034-98872021000400527","journal-title":"Rev Med Chil"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.33588\/rn.7309.2021364","article-title":"Guillain-Barre syndrome during COVID-19 pandemic: experience from a referral healthcare center in Mexico","volume":"73","author":"L\u00f3pez-Hern\u00e1ndez JC","year":"2021","unstructured":"L\u00f3pez-Hern\u00e1ndez JC, P\u00e9rez-Valdez EY, Le\u00f3n-Manr\u00edquez E, et al.. Guillain-Barre syndrome during COVID-19 pandemic: experience from a referral healthcare center in Mexico. Rev Neurol. 2021, 73:315-20. 10.33588\/rn.7309.2021364","journal-title":"Rev Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.12.0.451","article-title":"Electrophysiologic findings in patients with COVID-19 and quadriparesia in the northwest of Iran, a case series study and literature review","volume":"12","author":"Eslamian F","year":"2021","unstructured":"Eslamian F, Taleschian-Tabrizi N, Izadseresht B, Shakouri SK, Gholian S, Rahbar M. Electrophysiologic findings in patients with COVID-19 and quadriparesia in the northwest of Iran, a case series study and literature review. Caspian J Intern Med. 2021, 12:S451-9. 10.22088\/cjim.12.0.451","journal-title":"Caspian J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-021-00266-5","article-title":"Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature","volume":"11","author":"Islam B","year":"2021","unstructured":"Islam B, Ahmed M, Islam Z, Begum SM. Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature. Skelet Muscle. 2021, 11:10. 10.1186\/s13395-021-00266-5","journal-title":"Skelet Muscle"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15159","article-title":"Neurological manifestations in patients hospitalized with COVID-19: a retrospective analysis from a large cohort in Northern Italy","volume":"53","author":"Travi G","year":"2021","unstructured":"Travi G, Rossotti R, Merli M, et al.. Neurological manifestations in patients hospitalized with COVID-19: a retrospective analysis from a large cohort in Northern Italy. Eur J Neurosci. 2021, 53:2912-22. 10.1111\/ejn.15159","journal-title":"Eur J Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.23736\/S1973-9087.21.06663-6","article-title":"Unusual sensory-motor neuropathies in post Covid-19 patients admitted in rehabilitation hospitals: a case-series [In Press]","author":"Berra E","year":"2021","unstructured":"Berra E, Fundar\u00f2 C, Chimento P, Buonocore M. Unusual sensory-motor neuropathies in post Covid-19 patients admitted in rehabilitation hospitals: a case-series [In Press]. Eur J Phys Rehabil Med. 2021, 10.23736\/S1973-9087.21.06663-6","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","volume":"76","author":"Sedaghat Z","year":"2020","unstructured":"Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020, 76:233-5. 10.1016\/j.jocn.2020.04.062","journal-title":"J Clin Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie S","year":"2021","unstructured":"Keddie S, Pakpoor J, Mousele C, et al.. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome. Brain. 2021, 144:682-93. 10.1093\/brain\/awaa433","journal-title":"Brain"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04449-8","article-title":"Early Guillain-Barr\u00e9 syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital","volume":"41","author":"Ottaviani D","year":"2020","unstructured":"Ottaviani D, Boso F, Tranquillini E, et al.. Early Guillain-Barr\u00e9 syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020, 41:1351-4. 10.1007\/s10072-020-04449-8","journal-title":"Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00909","article-title":"COVID-19 and Guillain-Barr\u00e9 syndrome: a case report and review of literature","volume":"11","author":"Zito A","year":"2020","unstructured":"Zito A, Alfonsi E, Franciotta D, et al.. COVID-19 and Guillain-Barr\u00e9 syndrome: a case report and review of literature. Front Neurol. 2020, 11:909. 10.3389\/fneur.2020.00909","journal-title":"Front Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9110965","article-title":"COVID-19 as a trigger of recurrent Guillain-Barr\u00e9 syndrome","volume":"9","author":"McDonnell EP","year":"2020","unstructured":"McDonnell EP, Altomare NJ, Parekh YH, Gowda RC, Parikh PD, Lazar MH, Blaser MJ. COVID-19 as a trigger of recurrent Guillain-Barr\u00e9 syndrome. Pathogens. 2020, 9:965. 10.3390\/pathogens9110965","journal-title":"Pathogens"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.09.029","article-title":"Covid-19 associated Guillain-Barre syndrome: contrasting tale of four patients from a tertiary care centre in India","volume":"39","author":"Nanda S","year":"2021","unstructured":"Nanda S, Handa R, Prasad A, et al.. Covid-19 associated Guillain-Barre syndrome: contrasting tale of four patients from a tertiary care centre in India. Am J Emerg Med. 2021, 39:125-8. 10.1016\/j.ajem.2020.09.029","journal-title":"Am J Emerg Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04517-z","article-title":"Correction to: new clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases","volume":"41","author":"Assini A","year":"2020","unstructured":"Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. Correction to: new clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. 2020, 41:2307. 10.1007\/s10072-020-04517-z","journal-title":"Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09912-2","article-title":"Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19)","volume":"267","author":"Fern\u00e1ndez-Dom\u00ednguez J","year":"2020","unstructured":"Fern\u00e1ndez-Dom\u00ednguez J, Ameijide-Sanluis E, Garc\u00eda-Cabo C, Garc\u00eda-Rodr\u00edguez R, Mateos V. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol. 2020, 267:2495-6. 10.1007\/s00415-020-09912-2","journal-title":"J Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.04.007","article-title":"Covid-19 and Guillain-Barr\u00e9 syndrome: more than a coincidence!","volume":"176","author":"El Otmani H","year":"2020","unstructured":"El Otmani H, El Moutawakil B, Rafai MA, et al.. Covid-19 and Guillain-Barr\u00e9 syndrome: more than a coincidence!. Rev Neurol (Paris). 2020, 176:518-9. 10.1016\/j.neurol.2020.04.007","journal-title":"Rev Neurol (Paris)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano G","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020, 382:2574-6. 10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14368","article-title":"SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: AIDP variant with a favourable outcome","volume":"27","author":"Lascano AM","year":"2020","unstructured":"Lascano AM, Epiney JB, Coen M, et al.. SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: AIDP variant with a favourable outcome. Eur J Neurol. 2020, 27:1751-3. 10.1111\/ene.14368","journal-title":"Eur J Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.34172\/icnj.2020.18","article-title":"Guillain-Barr\u00e9 syndrome as a neurological complication of COVID-19 infection: a case series and review of the literature","volume":"7","author":"Mozhdehipanah H","year":"2020","unstructured":"Mozhdehipanah H, Paybast S, Gorji R. Guillain-Barr\u00e9 syndrome as a neurological complication of COVID-19 infection: a case series and review of the literature. Int Clin Neurosci J. 2020, 7:156-61. 10.34172\/icnj.2020.18","journal-title":"Int Clin Neurosci J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress JB","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P. COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve. 2020, 62:485-91. 10.1002\/mus.27024","journal-title":"Muscle Nerve"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh S","year":"2021","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021, 268:1133-70. 10.1007\/s00415-020-10124-x","journal-title":"J Neurol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions","volume":"92","author":"Filosto M","year":"2021","unstructured":"Filosto M, Cotti Piccinelli S, Gazzina S, et al.. Guillain-Barr\u00e9 syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021, 92:751-6. 10.1136\/jnnp-2020-324837","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao H","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020, 19:383-4. 10.1016\/S1474-4422(20)30109-5","journal-title":"Lancet Neurol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.04.003","article-title":"COVID-19 may induce Guillain-Barr\u00e9 syndrome","volume":"176","author":"Camdessanche JP","year":"2020","unstructured":"Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barr\u00e9 syndrome. Rev Neurol (Paris). 2020, 176:516-8. 10.1016\/j.neurol.2020.04.003","journal-title":"Rev Neurol (Paris)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000741","article-title":"Guillain-Barr\u00e9 syndrome related to COVID-19 infection","volume":"7","author":"Alberti P","year":"2020","unstructured":"Alberti P, Beretta S, Piatti M, et al.. Guillain-Barr\u00e9 syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020, 7:e741. 10.1212\/NXI.0000000000000741","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12419","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis","volume":"25","author":"Hasan I","year":"2020","unstructured":"Hasan I, Saif-Ur-Rahman KM, Hayat S, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis. J Peripher Nerv Syst. 2020, 25:335-43. 10.1111\/jns.12419","journal-title":"J Peripher Nerv Syst"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-020-01421-3","article-title":"Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barr\u00e9 syndrome","volume":"120","author":"Galassi G","year":"2020","unstructured":"Galassi G, Marchioni A. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barr\u00e9 syndrome. Acta Neurol Belg. 2020, 120:1067-75. 10.1007\/s13760-020-01421-3","journal-title":"Acta Neurol Belg"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25987","article-title":"Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in Covid-19","volume":"89","author":"Fragiel M","year":"2021","unstructured":"Fragiel M, Mir\u00f3 \u00d2, Llorens P, et al.. Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in Covid-19. Ann Neurol. 2021, 89:598-603. 10.1002\/ana.25987","journal-title":"Ann Neurol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000119","article-title":"Human immunoglobulin versus plasmapheresis in Guillain-Barre syndrome and myasthenia gravis: a meta-analysis","volume":"18","author":"Ortiz-Salas P","year":"2016","unstructured":"Ortiz-Salas P, Velez-Van-Meerbeke A, Galvis-Gomez CA, Rodriguez Q JH. Human immunoglobulin versus plasmapheresis in Guillain-Barre syndrome and myasthenia gravis: a meta-analysis. J Clin Neuromuscul Dis. 2016, 18:1-11. 10.1097\/CND.0000000000000119","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Mech\u00e9 FG","year":"1992","unstructured":"van der Mech\u00e9 FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group. N Engl J Med. 1992, 326:1123-9. 10.1056\/NEJM199204233261705","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001798.pub3","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Chevret S","year":"2017","unstructured":"Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2017, 2:CD001798. 10.1002\/14651858.CD001798.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. The Guillain-Barr\u00e9 syndrome Study Group","volume":"35","year":"1985","unstructured":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. The Guillain-Barr\u00e9 syndrome Study Group. Neurology. 1985, 35.1096-104. 10.1212\/WNL.35.8.1096","journal-title":"Neurology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","volume":"41","year":"1997","unstructured":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome. Ann Neurol. 1997, 41.298-306. 10.1002\/ana.410410304","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1997.tb00027.x","article-title":"Plasma exchange versus intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","volume":"1","author":"Hughes RA","year":"1997","unstructured":"Hughes RA. Plasma exchange versus intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Ther Apher. 1997, 1:129-30. 10.1111\/j.1744-9987.1997.tb00027.x","journal-title":"Ther Apher"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001446.pub5","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes RA","year":"2016","unstructured":"Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2016, 10:CD001446. 10.1002\/14651858.CD001446.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","author":"Hughes RA","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014, CD002063. 10.1002\/14651858.CD002063.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230406","article-title":"Plasmapheresis and Guillain-Barr\u00e9 syndrome: analysis of prognostic factors and the effect of plasmapheresis","volume":"23","author":"McKhann GM","year":"1988","unstructured":"McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA. Plasmapheresis and Guillain-Barr\u00e9 syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol. 1988, 23:347-53. 10.1002\/ana.410230406","journal-title":"Ann Neurol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-138577","article-title":"COVID-19: current understanding of its pathophysiology, clinical presentation and treatment","volume":"97","author":"Parasher A","year":"2021","unstructured":"Parasher A. COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J. 2021, 97:312-20. 10.1136\/postgradmedj-2020-138577","journal-title":"Postgrad Med J"},{"key":"ref46","article-title":"Guillain-Barr\u00e9 syndrome and other immune-mediated meuropathies","author":"Hauser SL","year":"2018","unstructured":"Hauser SL, Amato AA. Guillain-Barr\u00e9 syndrome and other immune-mediated meuropathies. Harrison's Principles of Internal Medicine. Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (ed): McGraw Hill, New York City, NY; 2018."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20620","article-title":"Long-term prognosis of Guillain-Barr\u00e9 syndrome not determined by treatment options?","volume":"8","author":"Wang Y","year":"2017","unstructured":"Wang Y, Lang W, Zhang Y, Ma X, Zhou C, Zhang HL. Long-term prognosis of Guillain-Barr\u00e9 syndrome not determined by treatment options?. Oncotarget. 2017, 8:79991-80001. 10.18632\/oncotarget.20620","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/81477-post-covid-19-guillain-barr-syndrome-a-case-report-with-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:22Z","timestamp":1707507742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/81477-post-covid-19-guillain-barr-syndrome-a-case-report-with-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.21246","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,14]]}}}